ConvaTec Group plc (GB:CTEC) has released an update.
ConvaTec Group plc reports a positive trading update with a 5.2% increase in revenue and strong performance across all care categories, particularly in the US and Europe. The company is on track to meet its full-year financial guidance, with high expectations for organic revenue growth and adjusted operating profit margins. Innovative new product launches and clinical evidence generation are contributing to ConvaTec’s confident outlook for medium-term growth.
For further insights into GB:CTEC stock, check out TipRanks’ Stock Analysis page.
